Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Table 2

Comparison between the results from oral glucose tolerance test, lipid profile, blood pressure measurement, and ECG characteristics between the three groups.

	Group 1		Group 2		Group 3
	Obese		Lean PCOS		Obese PCOS
	n		n		n
Fasting blood glucose (mmol/L)	125	4.37±1.02	94	4.25±0.75^∗	82	4.63±0.94
Blood glucose on 60 min of OGTT (mmol/L)	110	7.62±1.99^∧	75	6.72±2.08^∗∗	78	7.87±2.09
Blood glucose on 120 min of OGTT (mmol/L)	119	5.86±1.62	74	5.70±1.45	81	6.06±1.54
Fasting IRI (mU/L)	86	18.24±9.86^∧∧∧	72	8.16±4.22^∗∗∗	69	20.35±11.67
IRI on 60 min of OGTT (mU/L)	54	108.70±78.26^∧∧	62	65.50±49.05^∗∗∗	54	129.26±79.32
IRI on 120 min of OGTT (mU/L)	57	66.69±50.11^∧	61	39.40±33.11^∗∗∗	53	90.22±74.22
HOMA index	86	3.80±2.41^∧∧∧	72	1.56±0.97^∗∗∗	68	4.32±2.69
Fasting glucose/insulin ratio	86	0.34±0.22^∧∧∧	72	0.68±0.39^∗∗∗	68	0.32±0.22
Dislipidemia (%)	125	44.0%^∧∧∧	91	15.4%^∗∗∗	81	40.7%
Treatment for dislipidemia (%)	125	4.8%	91	1.1%	80	2.5%
Total cholesterol (mmol/L)	122	4.73±0.94	89	4.60±0.97	81	4.68±0.81
HDL cholesterol (mmol/L)	95	1.27±0.28^∧∧∧	52	1.52±0.40^∗∗	66	1.28±0.34
LDL cholesterol (mmol/L)	95	2.73±0.88	52	2.78±0.94	65	2.64±0.73
VLDL cholesterol (mmol/L)	94	0.67±0.43^∧∧∧	49	0.37±0.18^∗∗∗	64	0.71±0.43
Triglycerides (mmol/L)	125	1.76±0.75^∧∧∧	89	0.91±0.37^∗∗∗	80	1.56±0.72
Arterial hypertension (%)	125	31.2%^∧∧∧	93	1.1%^∗∗∗	81	29.6%
Treatment for arterial hypertention (%)	125	12.8%^∧∧	93	1.1%^∗∗∗	81	18.5%
Systolic blood pressure (mmHg)	125	124.00±12.44^∧∧∧	90	113.78±12.09^∗∗∗	81	123.77±14.41
Diastolic blood pressure (mmHg)	125	80.00±9.20^∧∧∧	90	73.11±8.16^∗∗∗	81	80.06±10.29
cQT-interval (sec)	19	0.41±0.02	9	0.41±0.04	18	0.40±0.03
RR-interval (sec)	22	0.73±0.13^∧∧	9	0.89±0.16^∗	19	0.74±0.09
Heart rate (bpm)	27	84.48±11.46^∧∧∧	9	68.22±9.64^∗	25	79.48±8.95

* 𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 between group 2 and group 3.
^∧𝑃<0.05; ^∧∧𝑃<0.01; ^{∧∧ ∧}𝑃<0.001 between group 1 and group 2.
n = number of patients.